Vascular endothelial growth factor as a target for antiangiogenic therapy

Journal of Clinical Oncology

Volumn 18, Issue 21 SUPPL., 2000, Pages

  Gordon, M S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; CANCER REGRESSION; CONFERENCE PAPER; EMBRYO DEVELOPMENT; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANGIOGENESIS INHIBITORS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034329395     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Tumor angiogenesis: Therapeutic implications
2. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy
3. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases